Why This Dividend Stock Is a Buy
Successful long-term investing is more inaction than action. This means that investors should find thriving companies in growing industries, buy them, hold them, and occasionally monitor their fundamentals to make sure the investment thesis is intact.
As more innovative treatments are developed for chronic conditions, the global medical devices industry is expected to steadily grow. That's why the market research firm Precedence Research anticipates that the global medical devices industry will compound at 5.5% annually from $550 billion in 2021 to $850 billion by 2030.
As one of the largest medical device companies in the world, Stryker (NYSE: SYK) will be a major beneficiary of this positive industry outlook. Let's dig even deeper into why the stock looks like it could be a solid buy for dividend investors.
Source Fool.com
